GeneL.ColiceMD

PubMed

• Effect of Tezepelumab on the Humoral Immune Response to Seasonal Quadrivalent Influenza Vaccination in Patients with Moderate to Severe Asthma: The Phase 3b VECTOR Study.
  Cąpała-Szczurko, I., Roseti, S., Chen, C., Caveney, S., Aksyuk, A., Streicher, K., Ponnarambil, S., Cole, J., Colice, G.> ;Pulmonary Therapy. 2024 Mar 1
• 4 citations
  Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma.
  Nordenmark, L., Hellqvist, Å., Emson, C., Diver, S., Porsbjerg, C., Griffiths, J., Peterson, S., Pawlikowska, B., Parnes, J., Megally, A., Brightling, C., Newell, J., ...> ;NEJM Evidence. 2023 Oct 1
• 2 citations
  Tezepelumab for the treatment of severe asthma: a plain language summary of the PATHWAY and NAVIGATOR studies.
  Jonathan Corren, Andrew Menzies-Gow, Johan Bimmel, Anthony McGuinness, Gun Almqvist, Karin Bowen, Janet M Griffiths, Sandhia Ponnarambil, Arnaud Bourdin, Elliot Israel...> ;Immunotherapy. 2023 Nov 1
• 1 citations
  Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study.
  Andrew Menzies-Gow, Christopher S Ambrose, Gene Colice, Gillian Hunter, Bill Cook, Nestor A Molfino, Jean-Pierre Llanos, Elliot Israel> ;Advances in Therapy. 2023 Nov 1
• 3 citations
  Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR).
  Ian D Pavord, Flavia C L Hoyte, Andrew W Lindsley, Christopher S Ambrose, Joseph D Spahn, Stephanie L Roseti, Bill Cook, Janet M Griffiths, Åsa Hellqvist, Nicole Marti...> ;Annals of Allergy, Asthma & Immunology. 2023 Nov 1
• 1 citations
  Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma: The NAVIGATOR study.
  Andrew Menzies-Gow, Arnaud Bourdin, Geoffrey Chupp, Elliot Israel, Åsa Hellqvist, Gillian Hunter, Stephanie L Roseti, Christopher S Ambrose, Jean-Pierre Llanos, Bill C...> ;Annals of Allergy, Asthma & Immunology. 2023 Sep 1
• 15 citations
  Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials.
  Jonathan Corren, Andrew Menzies-Gow, Geoffrey Chupp, Elliot Israel, Stephanie Korn, Bill Cook, Christopher S Ambrose, Åsa Hellqvist, Stephanie L Roseti, Nestor A Molfi...> ;American Journal of Respiratory and Critical Care Medicine. 2023 Jul 1
• 26 citations
  Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
  Andrew Menzies-Gow, Michael E Wechsler, Christopher E Brightling, Stephanie Korn, Jonathan Corren, Elliot Israel, Geoffrey Chupp, Artur Bednarczyk, Sandhia Ponnarambil...> ;The Lancet. Respiratory Medicine. 2023 May 1
• 3 citations
  Efficacy and safety of tezepelumab in patients recruited in Japan who participated in the phase 3 NAVIGATOR study.
  Tamotsu Ishizuka, Andrew Menzies-Gow, Hiroshi Okada, Yasushi Fukushima, Nobuya Hayashi, Gene Colice, Sandhia Ponnarambil, Gillian Hunter, Hiroshi Odajima, Motohiro Ebi...> ;Allergology International. 2023 Jan 1
• 8 citations
  Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study.
  Jonathan Corren, Christopher S Ambrose, Janet M Griffiths, Åsa Hellqvist, Andrew W Lindsley, Jean-Pierre Llanos, Gene Colice, Andrew Menzies-Gow> ;Clinical and Experimental Allergy. 2023 Apr 1
• 1 citations
  Efficacy and safety of tezepelumab in patients with uncontrolled disease while receiving maintenance therapy for moderate or severe asthma.
  Jonathan Corren, Michael E Wechsler, Geoffrey Chupp, Stephanie L Roseti, Åsa Hellqvist, Neil Martin, Jean-Pierre Llanos, Christopher S Ambrose, Gene Colice> ;The Journal of Allergy and Clinical Immunology. in Practice. 2023 Mar 1
• 32 citations
  Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, pha...
  Michael E Wechsler, Andrew Menzies-Gow, Christopher E Brightling, Piotr Kuna, Stephanie Korn, Tobias Welte, Janet M Griffiths, Kinga Sałapa, Åsa Hellqvist, Gun Almqvis...> ;The Lancet. Respiratory Medicine. 2022 Jul 1
• 7 citations
  One-year safety and tolerability of tezepelumab in Japanese patients with severe uncontrolled asthma: results of the NOZOMI study.
  Masaharu Shinkai, Motohiro Ebisawa, Yasushi Fukushima, Satomi Takeuchi, Hiroshi Okada, Tatsuro Tokiyo, Nobuya Hayashi, Mami Takikawa, Gene Colice, Gun Almqvist> ;The Journal of Asthma. 2023 Mar 1
• 38 citations
  Baseline type 2 biomarker levels and response to tezepelumab in severe asthma.
  Jonathan Corren, Tuyet-Hang Pham, Esther Garcia Gil, Kinga Sałapa, Pin Ren, Jane R Parnes, Gene Colice, Janet M Griffiths> ;Allergy. 2022 Jun 1
• 16 citations
  Targeting TSLP in Asthma.
  Jane R Parnes, Nestor A Molfino, Gene Colice, Ubaldo Martin, Jonathan Corren, Andrew Menzies-Gow> ;Journal of Asthma and Allergy. 2022 Jan 1
• 9 citations
  Tezepelumab normalizes serum interleukin-5 and -13 levels in patients with severe, uncontrolled asthma.
  Tuyet-Hang Pham, Claudia Chen, Gene L. Colice, Jane R. Parnes, Janet M. Griffiths, Bill Cook> ;Annals of Allergy, Asthma & Immunology. 2021 Aug 14
• 21 citations
  Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma and Perennial Allergy.
  Jonathan Corren, Christopher S. Ambrose, Kinga Sałapa, Stephanie L. Roseti, Janet M. Griffiths, Jane R. Parnes, Gene L. Colice> ;The Journal of Allergy and Clinical Immunology. in Practice. 2021 Aug 3
• 96 citations
  Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-bl...
  Sarah Diver, Latifa Khalfaoui, Claire Emson, Sally E. Wenzel, Andrew Menzies-Gow, Michael E. Wechsler, James Johnston, Nestor Molfino, Jane R. Parnes, Ayman Megally, G...> ;The Lancet. Respiratory Medicine. 2021 Nov 1
• 28 citations
  Patient characteristics, biomarkers, and exacerbation risk in severe, uncontrolled asthma.
  Monica Kraft, Guy Brusselle, J. Mark FitzGerald, Ian D. Pavord, Matthew Keith, Malin Fagerås, Esther Garcia Gil, Ian Hirsch, Mitchell Goldman, Gene L. Colice> ;The European Respiratory Journal. 2021 Jun 10
• 304 citations
  Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.
  Andrew Menzies-gow, Jonathan Corren, Arnaud Bourdin, Geoffrey Chupp, Elliot Israel, Michael E. Wechsler, Christopher E. Brightling, Janet M. Griffiths, Åsa Hellqvist, ...> ;The New England Journal of Medicine. 2021 May 12
• 16 citations
  Functionality and Performance of an Accessorized Pre-Filled Syringe and an Autoinjector for At-Home Administration of Tezepelumab in Patients with Severe, Uncontrolled...
  Sady Alpizar, Ayman Megally, Claudia Chen, Abhi Raj, John Downie, Gene L. Colice> ;Journal of Asthma and Allergy. 2021 Apr 19
• 27 citations
  Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A Post Hoc Analysis of the Phase 2b PATHWAY Study.
  Claire Emson, Jonathan Corren, Kinga Sałapa, Åsa Hellqvist, Jane R. Parnes, Gene L. Colice> ;Journal of Asthma and Allergy. 2021 Feb 3
• 17 citations
  Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study.
  Jonathan Corren, Martin Karpefors, Åsa Hellqvist, Jane R. Parnes, Gene L. Colice> ;Journal of Asthma and Allergy. 2021 Jan 11
• 14 citations
  Tezepelumab Pharmacokinetics, Safety, and Tolerability After Administration via Vial-and-syringe, Accessorized Prefilled Syringe, or Autoinjector: A Randomized Trial i...
  Yanan Zheng, Lubna Abuqayyas, Ayman Megally, Rainard Fuhr, Kinga Sałapa, John Downie, Gene L. Colice> ;Clinical Therapeutics. 2021 Jan 1
• 35 citations
  DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepeluma...
  Andrew Menzies-Gow, Sandhia Ponnarambil, John Downie, Karin Bowen, Åsa Hellqvist, Gene L. Colice> ;Respiratory Research. 2020 Oct 21
• Join now to see all

Journal Articles

• Tralokinumab Did Not Demonstrate Oral Corticosteroid-Sparing Effects in Severe Asthma  
  Gene Colice, MD, The European Respiratory Journal